RecruitingPhase 1NCT07831876

A Study of Ear Nerve Stimulation to Treat Eye Inflammation

Assessment of Transcutaneous Auricular Vagus Nerve Stimulation for Ocular Inflammatory Conditions

Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

20 participants

Start Date

Sep 9, 2026

Study Type

INTERVENTIONAL

Conditions

Intraocular Lens Complication Ocular Inflammation Crystalline Lens; Chalcosis

Summary

The purpose of this study to find out whether a device that delivers mild electrical stimulation to the ear (transcutaneous auricular vagus nerve stimulation, or taVNS) can reduce inflammation in the eye in people with ocular inflammatory conditions. The device is called the Cymbathera One System.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Cymbathera One System for people with crystalline lens; chalcosis, intraocular lens complication, and other related conditions. The study is currently recruiting participants at 7 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECymbathera One System

Cymbathera One System provides transcutaneous electrical stimulation to the auricular branch of the vagus nerve

Locations(7)

Memorial Sloan Kettering at Basking Ridge (Consent Only)

Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Consent only)

Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Consent Only)

Montvale, New Jersey, United States

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only)

Commack, New York, United States

Memorial Sloan Kettering Westchester (Consent Only)

Harrison, New York, United States

Memorial Sloan Kettering Cancer Center (All Protocol Activites)

New York, New York, United States

Memorial Sloan Kettering Cancer Center @ Nassau (Consent only)

Uniondale, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07831876

Related Trials

Dextenza in the Post-op Management of Vitreoretinal Surgeries

NCT043714451 location

Functional IOL Implantation in Patients With Epiretinal Membrane

NCT067197392 locations

Comparison of Topical Treatment for Inflammatory Secretions of the Conjonctiva (Patients With Ocular Prostheses)

NCT056684551 location

Intraocular Lens Implant Registry Study

NCT062944051 location